These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 15951007)
1. Remarks on clinical data concerning dietary supplements that affect antithrombotic therapy. Lichtenstein AH Thromb Res; 2005; 117(1-2):71-3; discussion 113-5. PubMed ID: 15951007 [No Abstract] [Full Text] [Related]
2. The interaction of dietary supplements with antithrombotic agents: scope of the problem. Marder VJ Thromb Res; 2005; 117(1-2):7-13; discussion 39-42. PubMed ID: 16076481 [No Abstract] [Full Text] [Related]
3. The interference of botanicals and nutraceuticals with the effects of antithrombotic agents: how should the available evidence be weighed? De Smet PA Thromb Res; 2005; 117(1-2):19-24; discussion 39-42. PubMed ID: 16239022 [No Abstract] [Full Text] [Related]
4. Fish oil supplements. Med Lett Drugs Ther; 2006 Jul; 48(1239):59-60. PubMed ID: 16841020 [No Abstract] [Full Text] [Related]
5. Omega-3 fatty acids for the prevention of myocardial infarction and arrhythmias. Pepe M; Recchia FA Cardiovasc Ther; 2010 Aug; 28(4):e1-4. PubMed ID: 20633018 [No Abstract] [Full Text] [Related]
6. Clinical implications for patients on antithrombotic therapy while taking supplements. Ortel TL Thromb Res; 2005; 117(1-2):75-80; discussion 113-5. PubMed ID: 15961141 [No Abstract] [Full Text] [Related]
7. The pleiotropic effects of statins and omega-3 fatty acids against sepsis: a new perspective. Makris GC; Geroulakos G; Makris MC; Mikhailidis DP; Falagas ME Expert Opin Investig Drugs; 2010 Jul; 19(7):809-14. PubMed ID: 20470189 [TBL] [Abstract][Full Text] [Related]
8. Effect of dietary supplements on hemostasis: a case of bleeding in context of research and surveillance. Palmer ME Thromb Res; 2005; 117(1-2):33-8; discussion 39-42. PubMed ID: 16182344 [No Abstract] [Full Text] [Related]
10. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview. Woo JJ Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311 [No Abstract] [Full Text] [Related]
11. FDA perspectives on supplement use by patients on antithrombotic therapy. Kim MJ Thromb Res; 2005; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297 [No Abstract] [Full Text] [Related]
12. n-3 Polyunsaturated fatty acids are still underappreciated and underused post myocardial infarction. Khavandi A; Khavandi K; Greenstein A; Karsch K; Heagerty AM Heart; 2009 Apr; 95(7):540-1. PubMed ID: 19131442 [No Abstract] [Full Text] [Related]
13. Effects of dietary supplements on aspirin and other antiplatelet agents: an evidence-based approach. Desai D; Hasan A; Wesley R; Sunderland E; Pucino F; Csako G Thromb Res; 2005; 117(1-2):87-101; discussion 113-5. PubMed ID: 16115664 [No Abstract] [Full Text] [Related]
14. Safety considerations with omega-3 fatty acid therapy. Bays HE Am J Cardiol; 2007 Mar; 99(6A):35C-43C. PubMed ID: 17368277 [TBL] [Abstract][Full Text] [Related]
15. The rational use of dietary supplements and nutraceuticals in clinical medicine. Mechanick JI Mt Sinai J Med; 2005 May; 72(3):161-5. PubMed ID: 15915310 [TBL] [Abstract][Full Text] [Related]
16. n-3 Fatty acids and mood: the devil is in the detail. Richardson AJ Br J Nutr; 2008 Feb; 99(2):221-3. PubMed ID: 17919344 [No Abstract] [Full Text] [Related]
17. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. London B; Albert C; Anderson ME; Giles WR; Van Wagoner DR; Balk E; Billman GE; Chung M; Lands W; Leaf A; McAnulty J; Martens JR; Costello RB; Lathrop DA Circulation; 2007 Sep; 116(10):e320-35. PubMed ID: 17768297 [No Abstract] [Full Text] [Related]
18. Omega-3 oil: fish or pills? Consum Rep; 2003 Jul; 68(7):30-2. PubMed ID: 12841165 [No Abstract] [Full Text] [Related]
19. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding. May AE; Geisler T; Gawaz M Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396 [TBL] [Abstract][Full Text] [Related]